News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
206 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17856)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (103)
4 (175)
5 (247)
6 (211)
7 (266)
8 (238)
11 (138)
12 (206)
13 (219)
14 (240)
15 (174)
18 (169)
19 (181)
20 (151)
21 (145)
22 (81)
23 (1)
25 (165)
26 (155)
27 (94)
28 (19)
29 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
18
19
20
21
22
23
25
26
27
28
29
Press Releases
KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial
November 12, 2024
·
14 min read
Press Releases
Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates
November 12, 2024
·
19 min read
Press Releases
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
November 12, 2024
·
2 min read
Press Releases
Attivare Therapeutics Appoints David Sherris, Ph.D. as President, CEO, and Chairman
November 12, 2024
·
2 min read
Press Releases
Orthofix to Participate in Upcoming Investor Conferences
November 12, 2024
·
1 min read
Press Releases
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
November 12, 2024
·
5 min read
Press Releases
Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress
November 12, 2024
·
15 min read
Press Releases
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
November 12, 2024
·
5 min read
Press Releases
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
November 12, 2024
·
12 min read
Press Releases
Idorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific Sessions
November 12, 2024
·
5 min read
Previous
10 of 21
Next
